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معاجلة اْلِتهاب الشَّغاِف الَعدوائّي للصّمام األهبر 
بالبكترييا الزائفة الزجنارية باألدوية عند مريض غسيل 
الكلى
كوثر�سلمان ح�سن، داوؤود الريامي
امللخ�ص: التهاب ال�سغاف العدوائي عند مر�سى غ�سيل الكلى عدوى خطرية حتمل ن�سبة وفاة مرتفعة. عادة ما ي�سبب هذا الإلتهاب البكترييا 
اإيجابية اجلرام ومن النادر اأن ت�سببه البكرتيا �سلبية اجلرام. غالبا ما يت�سمن العالج الناجع ا�ستبدال ال�سمام امل�ساب جراحيا، بالإ�سافة 
اإىل ال�ستخدام طويل الأجل للم�سادات احليوية، بينما ُيَعد جناح العالج بامل�سادات احليوية وحدها اأمر نادر احلدوث. يف هذا التقرير ن�سف 
حالة التهاب ال�سغاف الَعدوائي بالبكترييا الزائفة الزجنارية يف مري�س على غ�سيل الكلى عولج بامل�سادات احليوية لوحدها.  
مفتاح الكلمات: الزائفة الزجنارية، التهاب ال�سغاف الَعدوائي، غ�سيل الكلى، املعاجلة بامل�سادات احليوية، تقرير حالة، ُعمان.
abstract: Infective endocarditis (IE) in patients on dialysis is a serious infection with a high mortality rate. 
It is usually caused by Gram positive bacteria with Gram negative organisms being relatively rare as a cause. 
Recommended treatment usually involves surgical valve replacement and the extended use of antibiotics. Successful 
treatment with antibiotics alone is rare. We report a case of IE caused by Pseudomonas aeruginosa in a patient on 
dialysis treated solely with antibiotics. 
Keywords: Pseudomonas aeruginosa; Infective endocarditis; Dialysis; Treatment, antibiotic; Case report; Oman.
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Infective endocarditis caused by Pseudomonas aeruginosa is rarely seen in clinical practice. It has been reported mainly 
in intravenous (IV) drug abusers.1,2 P. aeruginosa 
is also an occasional cause of nosocomial 
endocarditis, accounting for 10% of cases in one 
small intensive care unit (ICU) series.3 It carries 
a very high mortality rate of 80% necessitating, 
therefore, early diagnosis and intervention. The 
clinical outcome of right-sided endocarditis has 
improved with cure rates reaching 84% while 
that of the left side remains 33%.4 This sub- 
optimal outcome is partly due to increasing 
resistance to beta-lactams and aminoglycosides.1,4,5 
Fluoroquinoloes, on the other hand, seem to be 
more potent against Pseudomonas.6,7 Numerous 
studies have shown significantly better outcomes 
with combined medical/surgical treatment.8-11 
We report a haemodialysis patient who developed 
aortic regurgitation following catheter related P. 
aeruginosa endocarditis and describe her medical 
management and the outcome.
Case report
A 49 year-old Omani woman on dialysis with a past 
medical history of hypertension, diabetes, coronary 
artery disease, and end-stage renal disease presented 
to our hospital with uraemia. She was started on 
maintenance haemodialysis via a right internal 
jugular tunnelled cuffed catheter. A week later she 
had placement of an arteriovenous fistula (AVF). 
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Two weeks following the insertion of the catheter 
she developed fever and generalised weakness. 
Blood cultures taken from the central line grew 
P. aeruginosa. She was treated with ciprofloxacin 
and tazocin. She improved on this treatment and 
the tazocin was changed to amikacin after each 
dialysis. Subsequent surveillance blood cultures 
after 4 and 6 weeks of the first blood culture were 
negative. She was investigated with transthoracic 
echocardiography which reported no evidence of 
thrombi or vegetations. Given that her AVF was 
maturing and could be potentially used for dialysis 
only a month after the bacteraemia, the central 
line was kept for dialysis. However, one week later, 
before the line was removed, she presented with 
fever, generalised weakness, sore throat and dry 
cough. Her examination revealed a temperature 
of 37.9°C, blood pressure of 180/70 mmHg, mild 
pedal oedema and no signs of inflammation on 
the skin overlying the tunnelled catheter, but mild 
crusting at the exit site. Her body weight was 65 
kg. Her systemic examination was remarkable for a 
new diastolic murmur. Her investigations reported 
normal white blood cell (WBC) count and her chest 
X-ray reported no pneumonia. She continued to 
be sick and febrile despite initial management of 
presumed community-acquired pneumonia. At this 
stage, a catheter related infection was presumed and 
she was treated with vancomycin and amikacin. The 
tunnelled catheter was removed as her AVF was 
ready to be used for dialysis. Blood cultures grew 
P. aeruginosa. Transthoracic echocardiography 
(TTE) showed a well-circumscribed small mass 
attached to the non-coronary and right coronary 
cusp of the aortic valve suggestive of vegetation 
[Figure 1]. Transoesophageal echocardiography 
showed a huge vegetation of 2 cm on the left 
and non-coronary cusps of the aortic valve 
with no aortic root abscess. The cardiothoracic 
surgeon suggested valve replacement in addition 
to medical management with ceftazidime and 
amikacin. However, the patient strongly refused the 
surgery. On medical treatment alone she showed 
a remarkable improvement. TTE was done one 
month post antibiotics commencement. It showed 
evidence of severe aortic regurgitation (AR) and 
mobile vegetation attached mostly to the right 
coronary cusp. The large vegetation on the non-
 
Figure 1: Apical view transthoracic echocardiography 
scan showing large vegetation seen on the aortic valve.
 
Figure 2: Apical view transesophageal 
echocardiography scan showing decrease in the size of 
previous vegetation.
 
Figure 3: Short axis, aortic view echocardiography 
scan showing total clearance of the vegetation.
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coronary cusp was no longer seen and only small 
vegetation was seen on the left corornary cusp 
[Figure 2]. A repeat echocardiography 2 weeks 
later showed a mildly thickened aortic valve, but no 
vegetation [Figure 3]. In the last follow-up, one year 
later, the patient continued to do well clinically.
Discussion
Pseudomonas bacteraemia is a nosocomial problem 
being the third most frequent cause of Gram 
negative bacteraemia.12 Our patient had a central 
line which was the culprit for her bacteraemia and 
subsequent endocarditis.  Endocarditis caused 
by this pathogen is very serious with a very high 
mortality rate.13 Patients with left-sided valvular 
infections, often develop rapidly progressive 
symptoms that are due to either congestive heart 
failure or an embolism of large or medium-sized 
arteries. Ring and annular abscesses are also 
frequent complications. 
Pseudomonas endocarditis is associated 
with high mortality. This is explained by the fact 
that beta-lactams have a slow bactericidal effect 
on the organism and resistance to the drugs 
develops rapidly. Thus, treatment of P. aeruginosa 
endocarditis usually necessitates the combination 
of antibiotics and surgery to achieve a cure.14 Valve 
replacement was offered to our patient, but she 
persistently refused any surgical interventions. She 
was managed with a combination of ceftazidime 
(1 g three times a day) and amikacin (500 mg once/
day, on three days of week with dialysis, to achieve 
trough levels below 5 mg/L and peak levels between 
20–30 mg/L). After ten weeks the vegetation 
had completely disappeared. Medical treatment 
alone in left-sided infective endocarditis caused 
by P. aeruginosa was previously reported to be 
successful.15
Conclusion
We reported the cure of a case of endocarditis 
caused by P. aeruginosa with ceftazidime and 
amikacin. In the case of catheter related bacteremia 
with Pseudomonas, the line should be removed as 
soon as possible. 
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